PATRICK STANG: Open Payments
NPI 1639100183 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 24 payments from 11 companies in 2025. Trend: 2023 $482 · 2024 $452 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $137 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
Products named: REXULTI, COBENFY, UZEDY, VRAYLAR, ABILIFY MAINTENA, INGREZZA, Qelbree, Auvelity.
Industry payments across KS — which companies pay providers there.
